Uterine fibroids (leiomyomas) are the most common benign tumors in women of reproductive age, affecting approximately 70–80% of women by age 50. They develop from abnormal smooth muscle cell proliferation in an estrogen-dominant uterine environment, manifesting as intramural (within the myometrium), subserosal (protruding outward), or submucosal (distorting the endometrial cavity) growths. Conventional management focuses on symptom suppression (heavy bleeding management with progestins or tranexamic acid, pain control) or surgical removal (myomectomy/hysterectomy). However, homeopathy offers a constitutional approach targeting the root estrogen metabolism dysregulation, potentially halting fibroid growth and promoting natural regression.
Menorrhagia (excessive menstrual bleeding) from fibroids is profoundly debilitating: patients describe flooding requiring hourly pad changes, large dark clots, and cycles extending 10–12 days. This chronic blood loss leads to iron-deficiency anemia manifesting as profound fatigue, dyspnea, palpitations, and reduced capacity for work or family activities. Conventional management relies on hormonal agents (Depo-Provera, progestin-releasing IUDs) or antifibrinolytic drugs (tranexamic acid), which suppress bleeding temporarily but do not address underlying fibroid proliferation or estrogen dominance.
Unexplained female infertility—defined as failure to conceive after 12 months of unprotected intercourse in women under 35 (or 6 months in women over 35) despite normal basic fertility investigations—affects approximately 10% of reproductive-age women. Many unexplained infertility cases involve subclinical endometrial dysfunction: reduced endometrial thickness (<7 mm), loss of trilaminar pattern on ultrasound, or impaired endometrial gene expression despite normal hormonal profile. Fibroids, particularly submucosal types, directly distort the endometrial cavity and impair receptivity. Additionally, estrogen dominance in fibroid-bearing uteri creates a systemic endocrine environment hostile to embryo implantation.
Constitutional homeopathic treatment targets the estrogen metabolism dysregulation and myometrial smooth muscle hyperproliferation underlying both fibroids and endometrial dysfunction. Over 6–12 months of individualized remedy selection based on comprehensive case analysis (menstrual history, bleeding patterns, IUI/IVF outcomes, implantation failures, pregnancy loss dates, emotional triggers for symptom flares), homeopathic treatment rebalances estrogen clearance pathways, normalizes myometrial differentiation, restores uterine vascularity, and allows endometrial thickness and trilaminar pattern to recover naturally. Fibroid regression is typically documented on serial ultrasound as volume declines and vascularity normalizes; menstrual flow normalizes from 10–12 days to 4–5 day cycles; and endometrial receptivity improves sufficient for spontaneous conception.
At Gupta Computerised Homeopathic Clinic, Prof. Dr. (Mrs.) Neeraj Gupta combines detailed pelvic ultrasound assessment (fibroid mapping: diameter in mm, volume in mL, vascularity), endometrial thickness and pattern documentation, complete blood count and serum ferritin profiling (anemia evaluation from menorrhagia), hormonal baseline (AMH, Day 3 FSH, LH, prolactin), and comprehensive fertility history (IUI/IVF attempts, implantation patterns, miscarriage dates and gestation weeks) to design constitutional remedies addressing the patient's unique estrogen-dominant phenotype. With 30+ years of experience treating fibroids and infertility in Delhi and Ghaziabad, she provides in-person consultations at Shakarpur (East Delhi) and Vaishali (Ghaziabad) clinics, plus online consultations with home medicine delivery for outstation and international patients.